69. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Joint Meeting mit der Mexikanischen und Kolumbianischen Gesellschaft für Neurochirurgie
Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.
03.06. - 06.06.2018, Münster
ePoster
Neuro-Oncology: Clinical
Meeting Abstract
(P052)
[Full Text]
TTFields for newly diagnosed glioblastoma: Impact of consultation strategy
Haj A, Proescholdt M, Doenitz C, Hohenberger C, Brawanski A[Full Text]
Meeting Abstract
(P053)
[Full Text]
Unusual malignant course of a pilocytic astrocytoma: relevance of the assessment of H3F3A K27M mutation in adult patients
Kellermann S, Hamisch C, Grau S, Goldbrunner R, Hampl J[Full Text]
Meeting Abstract
(P054)
[Full Text]
Deep seated not accessible glioblastoma multiforme – analysis of patients’ overall survival after stereotactic biopsy and adjuvant treatment
Brüning AR, Lehmann A, Rathert J, Gerlach R[Full Text]
Meeting Abstract
(P055)
[Full Text]
Influence of clinical and molecular markers on survival of primary glioblastoma
Ahmadipour Y, Gembruch O, Pierscianek D, Zkan N, Müller O, Sure U, El Hindy N[Full Text]
Meeting Abstract
(P056)
[Full Text]
5-ALA – photodynamic therapy in recurrent malignant glioma – a retrospective data analysis
Schroeteler J, Hetkamp T, Schwake M, Ewelt C, Stummer W[Full Text]
Meeting Abstract
(P057)
[Full Text]
Clinicoradiographic key features of biopsy-proven treatment-induced necrosis in patients with malignant glioma
Winter SF, Löbel F, Vaios EJ, Bertalan MS, Bussière M, Shih HA, Muzikansky A, Martinez-Lage M, Vajkoczy P, Dietrich J[Full Text]
Meeting Abstract
(P058)
[Full Text]
Impact of carmustine implantation in first recurrence of glioblastoma patients – a retrospective monocentric analysis
Köber S, Kremer B, Kamp MA, Steiger HJ, Sabel M, Rapp M[Full Text]
Meeting Abstract
(P059)
[Full Text]
Surgical and oncological management of WHO grade III gliomas in the era of molecular-genetic markers
Delev D, Heiland DH, Haaker G, Franco P, Schnell O[Full Text]
Meeting Abstract
(P060)
[Full Text]
Persisting FLAIR-hyperintensity at follow-up after resection of glioblastoma correlates with localization of recurrence
Bettag C, Sachkova A, Psychogios M, Schregel K, Rohde V, Malinova V[Full Text]
Meeting Abstract
(P061)
[Full Text]
Investigation of the interaction of simultaneously applied irradiation and tumor treating fields (TTFields) using a Geant4 simulation
Mayer M, Hürtgen G, Schlenter M, Eble MJ, Stahl A[Full Text]
Meeting Abstract
(P062)
[Full Text]
The impact of carmustine implantation A retrospective monocentric analysis for recurrent high grade glioma patients
Köber S, Kamp MA, Steiger HJ, Sabel M, Rapp M[Full Text]
Meeting Abstract
(P063)
[Full Text]
The role of surgery in the treatment of recurrent glioblastoma
Pala A, Schmitz L, Knoll A, Hlavac M, König R, Wirtz CR, Coburger J[Full Text]
Meeting Abstract
(P064)
[Full Text]
Implantation of carmustine wafers after resection of malignant glioma with and without opening of the ventricular system
Hussein A, Abboud T, Mielke D, Rohde V[Full Text]
Meeting Abstract
(P065)
[Full Text]
Use of FET PET in glioblastoma patients undergoing neurooncological treatment including tumor-treating fields: Initial experiences
Ceccon G, Lazaridis L, Stoffels G, Rapp M, Lohmann P, Kebir S, Fink GR, Langen KJ, Glas M, Galldiks N[Full Text]
Meeting Abstract
(P066)
[Full Text]
Glioblastomatherapy withTTFields: Theroleofnurses in clinical routine
Kilias M, Pellet C, Hottinger A[Full Text]
Meeting Abstract
(P067)
[Full Text]
Multiple effects of temozolomide treatment on glioblastoma cells
Barciszewska AM, Belter A[Full Text]